Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3DBioSurfaces Technologies was a biotechnology company specializing in advanced surface modification and patterning technologies for life science research and diagnostics. The company's core platform, the 3D-BioGrid, utilized three-dimensional chemical gradients and patterns to enhance the sensitivity and specificity of biosensors and microarrays. Their technology was designed to improve the immobilization of biomolecules, such as proteins and DNA, by providing a more controlled microenvironment for molecular interactions. By overcoming the limitations of traditional 2D surface chemistries, 3DBioSurfaces aimed to provide higher signal-to-noise ratios and better reproducibility in analytical assays. The company was a spin-off from the University of Utah and primarily served the research tools market before becoming inactive.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3DBioSurfaces Technologies.